Key result
Central infusion of exendin-4 decreased femoral arterial blood flow and whole-body glucose utilization in awake mice during hyperinsulinemic-hyperglycemic conditions, without changing heart rate.
Why the study?
Does central brain GLP-1 signaling regulate arterial blood flow, heart rate, and insulin sensitivity in mice?
Does central brain GLP-1 signaling regulate arterial blood flow, heart rate, and insulin sensitivity in mice?
Central GLP-1 signaling is an essential component of circuits integrating cardiovascular and metabolic responses to hyperglycemia in mice.
No takes yet. Share an insight, caveat, or question.
Requires human validation before any clinical consideration; leaves open central GLP-1 effects on vascular-metabolic integration.
Cabou et al. (2008) studied this question. Exendin-4 (Ex4) vs. Control was evaluated on Femoral arterial blood flow, whole-body insulin-stimulated glucose utilization, and heart rate. Central infusion of exendin-4 decreased femoral arterial blood flow and whole-body glucose utilization in awake mice during hyperinsulinemic-hyperglycemic conditions, without changing heart rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: